annual CFI:
-$290.13M-$184.35M(-174.27%)Summary
- As of today (July 4, 2025), CLDX annual cash flow from investing activities is -$290.13 million, with the most recent change of -$184.35 million (-174.27%) on December 31, 2024.
- During the last 3 years, CLDX annual CFI has fallen by -$73.97 million (-34.22%).
- CLDX annual CFI is now -422.57% below its all-time high of $89.94 million, reached on December 31, 2022.
Performance
CLDX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$42.95M+$18.90M(+78.61%)Summary
- As of today (July 4, 2025), CLDX quarterly cash flow from investing activities is $42.95 million, with the most recent change of +$18.90 million (+78.61%) on March 31, 2025.
- Over the past year, CLDX quarterly CFI has increased by +$358.16 million (+113.63%).
- CLDX quarterly CFI is now -18.30% below its all-time high of $52.57 million, reached on March 31, 2023.
Performance
CLDX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$68.03M+$358.16M(+123.45%)Summary
- As of today (July 4, 2025), CLDX TTM cash flow from investing activities is $68.03 million, with the most recent change of +$358.16 million (+123.45%) on March 31, 2025.
- Over the past year, CLDX TTM CFI has increased by +$541.59 million (+114.37%).
- CLDX TTM CFI is now -48.51% below its all-time high of $132.13 million, reached on March 31, 2023.
Performance
CLDX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CLDX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -174.3% | +113.6% | +114.4% |
| 3 y3 years | -34.2% | +313.8% | +127.3% |
| 5 y5 years | -1798.7% | +95.5% | +187.4% |
CLDX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -422.6% | at low | -18.3% | +113.6% | -48.5% | +113.0% |
| 5 y | 5-year | -422.6% | at low | -18.3% | +113.6% | -48.5% | +113.0% |
| alltime | all time | -422.6% | at low | -18.3% | +113.6% | -48.5% | +113.0% |
CLDX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $42.95M(+78.6%) | $68.03M(-123.4%) |
| Dec 2024 | -$290.13M(+174.3%) | $24.05M(-49.6%) | -$290.13M(-40.2%) |
| Sep 2024 | - | $47.76M(-202.2%) | -$485.34M(-6.9%) |
| Jun 2024 | - | -$46.72M(-85.2%) | -$521.45M(+10.1%) |
| Mar 2024 | - | -$315.21M(+84.2%) | -$473.56M(+347.7%) |
| Dec 2023 | -$105.78M(-217.6%) | -$171.16M(-1569.7%) | -$105.78M(-209.5%) |
| Sep 2023 | - | $11.65M(+900.5%) | $96.59M(-10.6%) |
| Jun 2023 | - | $1.16M(-97.8%) | $108.01M(-18.3%) |
| Mar 2023 | - | $52.57M(+68.4%) | $132.13M(+46.9%) |
| Dec 2022 | $89.94M(-141.6%) | $31.21M(+35.3%) | $89.94M(+126.1%) |
| Sep 2022 | - | $23.07M(-8.8%) | $39.78M(-118.9%) |
| Jun 2022 | - | $25.28M(+143.6%) | -$210.07M(-15.7%) |
| Mar 2022 | - | $10.38M(-154.8%) | -$249.26M(+15.3%) |
| Dec 2021 | -$216.16M(+120.1%) | -$18.94M(-91.6%) | -$216.16M(+29.9%) |
| Sep 2021 | - | -$226.79M(+1530.2%) | -$166.36M(-1028.3%) |
| Jun 2021 | - | -$13.91M(-132.0%) | $17.92M(-123.4%) |
| Mar 2021 | - | $43.49M(+41.0%) | -$76.70M(-21.9%) |
| Dec 2020 | -$98.22M(-675.0%) | $30.85M(-172.6%) | -$98.22M(-22.0%) |
| Sep 2020 | - | -$42.51M(-60.8%) | -$125.85M(+61.7%) |
| Jun 2020 | - | -$108.53M(-594.1%) | -$77.82M(-442.1%) |
| Mar 2020 | - | $21.96M(+581.3%) | $22.75M(+33.2%) |
| Dec 2019 | $17.08M(-42.7%) | $3.22M(-41.6%) | $17.08M(-0.7%) |
| Sep 2019 | - | $5.52M(-169.3%) | $17.20M(+81.8%) |
| Jun 2019 | - | -$7.96M(-148.8%) | $9.46M(-69.1%) |
| Mar 2019 | - | $16.30M(+386.7%) | $30.62M(+2.7%) |
| Dec 2018 | $29.82M(-35.8%) | $3.35M(-250.7%) | $29.82M(+127.8%) |
| Sep 2018 | - | -$2.22M(-116.8%) | $13.09M(-22.9%) |
| Jun 2018 | - | $13.19M(-14.8%) | $16.97M(-57.1%) |
| Mar 2018 | - | $15.49M(-215.8%) | $39.56M(-14.9%) |
| Dec 2017 | $46.47M(-32.6%) | -$13.38M(-903.7%) | $46.47M(-47.0%) |
| Sep 2017 | - | $1.67M(-95.3%) | $87.63M(-13.1%) |
| Jun 2017 | - | $35.78M(+59.7%) | $100.89M(+53.4%) |
| Mar 2017 | - | $22.40M(-19.4%) | $65.77M(-4.6%) |
| Dec 2016 | $68.91M(-237.3%) | $27.78M(+86.2%) | $68.91M(+15.1%) |
| Sep 2016 | - | $14.92M(+2136.6%) | $59.87M(+4.6%) |
| Jun 2016 | - | $667.00K(-97.4%) | $57.21M(+41.7%) |
| Mar 2016 | - | $25.54M(+36.3%) | $40.38M(-180.5%) |
| Dec 2015 | -$50.19M(+22.4%) | $18.74M(+52.9%) | -$50.19M(-2.0%) |
| Sep 2015 | - | $12.26M(-175.9%) | -$51.24M(+12.7%) |
| Jun 2015 | - | -$16.16M(-75.1%) | -$45.48M(+84.0%) |
| Mar 2015 | - | -$65.03M(-467.5%) | -$24.72M(-39.7%) |
| Dec 2014 | -$41.01M(-47.0%) | $17.70M(-1.8%) | -$41.01M(-43.5%) |
| Sep 2014 | - | $18.02M(+291.8%) | -$72.53M(-14.7%) |
| Jun 2014 | - | $4.60M(-105.7%) | -$84.99M(-24.2%) |
| Mar 2014 | - | -$81.33M(+488.4%) | -$112.17M(+44.9%) |
| Dec 2013 | -$77.42M(+356.0%) | -$13.82M(-348.7%) | -$77.42M(+13.6%) |
| Sep 2013 | - | $5.56M(-124.6%) | -$68.14M(+0.6%) |
| Jun 2013 | - | -$22.58M(-51.5%) | -$67.71M(+87.8%) |
| Mar 2013 | - | -$46.58M(+926.6%) | -$36.05M(+112.3%) |
| Dec 2012 | -$16.98M(+687.9%) | -$4.54M(-175.8%) | -$16.98M(+286.0%) |
| Sep 2012 | - | $5.99M(-34.0%) | -$4.40M(>+9900.0%) |
| Jun 2012 | - | $9.08M(-133.0%) | -$34.00K(-99.9%) |
| Mar 2012 | - | -$27.51M(-442.0%) | -$34.93M(+1521.0%) |
| Dec 2011 | -$2.15M(-86.7%) | $8.04M(-22.3%) | -$2.15M(-19.8%) |
| Sep 2011 | - | $10.35M(-140.1%) | -$2.69M(-75.5%) |
| Jun 2011 | - | -$25.82M(-590.0%) | -$10.96M(+226.6%) |
| Mar 2011 | - | $5.27M(-29.8%) | -$3.36M(-79.2%) |
| Dec 2010 | -$16.16M(-135.8%) | $7.51M(+261.5%) | -$16.16M(-176.9%) |
| Sep 2010 | - | $2.08M(-111.4%) | $21.01M(+11.7%) |
| Jun 2010 | - | -$18.22M(+141.7%) | $18.81M(-48.9%) |
| Mar 2010 | - | -$7.54M(-116.9%) | $36.84M(-18.3%) |
| Dec 2009 | $45.09M(+344.0%) | $44.68M(<-9900.0%) | $45.09M(+7358.0%) |
| Sep 2009 | - | -$115.00K(-37.8%) | $604.60K(+515.1%) |
| Jun 2009 | - | -$185.00K(-126.1%) | $98.30K(-23.0%) |
| Mar 2009 | - | $710.00K(+264.9%) | $127.60K(-98.7%) |
| Dec 2008 | $10.15M(-2556.5%) | $194.60K(-131.3%) | $10.15M(+5.5%) |
| Sep 2008 | - | -$621.30K(+299.0%) | $9.62M(-32.8%) |
| Jun 2008 | - | -$155.70K(-101.5%) | $14.32M(+37.9%) |
| Mar 2008 | - | $10.74M(-3274.8%) | $10.38M(-2611.5%) |
| Dec 2007 | -$413.40K | -$338.20K(-108.3%) | -$413.40K(-112.5%) |
| Sep 2007 | - | $4.08M(-199.6%) | $3.31M(-190.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | -$4.09M(+6897.4%) | -$3.65M(+136.6%) |
| Mar 2007 | - | -$58.50K(-101.7%) | -$1.54M(-28.9%) |
| Dec 2006 | -$2.17M(-0.3%) | $3.38M(-217.6%) | -$2.17M(-66.0%) |
| Sep 2006 | - | -$2.88M(+44.7%) | -$6.37M(+58.0%) |
| Jun 2006 | - | -$1.99M(+190.5%) | -$4.03M(+61.4%) |
| Mar 2006 | - | -$684.40K(-16.9%) | -$2.50M(+15.0%) |
| Dec 2005 | -$2.17M(+31.2%) | -$823.50K(+53.3%) | -$2.17M(+51.1%) |
| Sep 2005 | - | -$537.30K(+18.3%) | -$1.44M(-30.4%) |
| Jun 2005 | - | -$454.20K(+26.6%) | -$2.07M(+16.8%) |
| Mar 2005 | - | -$358.70K(+304.4%) | -$1.77M(+6.9%) |
| Dec 2004 | -$1.66M(-192.6%) | -$88.70K(-92.4%) | -$1.66M(-165.4%) |
| Sep 2004 | - | -$1.17M(+644.7%) | $2.53M(-30.7%) |
| Jun 2004 | - | -$156.70K(-35.9%) | $3.65M(-1.4%) |
| Mar 2004 | - | -$244.30K(-106.0%) | $3.71M(+107.0%) |
| Dec 2003 | $1.79M(-312.9%) | $4.10M(-8843.1%) | $1.79M(-170.6%) |
| Sep 2003 | - | -$46.90K(-54.6%) | -$2.53M(-4.1%) |
| Jun 2003 | - | -$103.40K(-95.2%) | -$2.64M(-4.3%) |
| Mar 2003 | - | -$2.16M(+869.2%) | -$2.76M(+228.7%) |
| Dec 2002 | -$840.60K(+8.4%) | -$222.90K(+42.4%) | -$840.60K(+4.2%) |
| Sep 2002 | - | -$156.50K(-30.0%) | -$807.00K(-12.9%) |
| Jun 2002 | - | -$223.50K(-6.0%) | -$926.10K(+0.3%) |
| Mar 2002 | - | -$237.70K(+25.6%) | -$923.50K(+19.1%) |
| Dec 2001 | -$775.40K(-19.7%) | -$189.30K(-31.3%) | -$775.40K(-45.2%) |
| Sep 2001 | - | -$275.60K(+24.8%) | -$1.41M(+12.2%) |
| Jun 2001 | - | -$220.90K(+146.5%) | -$1.26M(+9.3%) |
| Mar 2001 | - | -$89.60K(-89.2%) | -$1.15M(+19.4%) |
| Dec 2000 | -$966.20K(-129.6%) | -$828.20K(+577.2%) | -$966.20K(-17.4%) |
| Sep 2000 | - | -$122.30K(+7.3%) | -$1.17M(+11.7%) |
| Jun 2000 | - | -$114.00K(-216.0%) | -$1.05M(+1.4%) |
| Mar 2000 | - | $98.30K(-109.5%) | -$1.03M(-131.6%) |
| Dec 1999 | $3.27M(-57.0%) | -$1.03M(<-9900.0%) | $3.27M(-54.0%) |
| Sep 1999 | - | $0.00(-100.0%) | $7.10M(-43.2%) |
| Jun 1999 | - | -$100.00K(-102.3%) | $12.50M(+3.3%) |
| Mar 1999 | - | $4.40M(+57.1%) | $12.10M(+59.2%) |
| Dec 1998 | $7.60M(+406.7%) | $2.80M(-48.1%) | $7.60M(+61.7%) |
| Sep 1998 | - | $5.40M(-1180.0%) | $4.70M(-687.5%) |
| Jun 1998 | - | -$500.00K(+400.0%) | -$800.00K(+166.7%) |
| Mar 1998 | - | -$100.00K(0.0%) | -$300.00K(-120.0%) |
| Dec 1997 | $1.50M(-850.0%) | -$100.00K(0.0%) | $1.50M(-11.8%) |
| Sep 1997 | - | -$100.00K(<-9900.0%) | $1.70M(-10.5%) |
| Jun 1997 | - | $0.00(-100.0%) | $1.90M(+11.8%) |
| Mar 1997 | - | $1.70M(+1600.0%) | $1.70M(-950.0%) |
| Dec 1996 | -$200.00K(-103.4%) | $100.00K(0.0%) | -$200.00K(-87.5%) |
| Sep 1996 | - | $100.00K(-150.0%) | -$1.60M(-42.9%) |
| Jun 1996 | - | -$200.00K(0.0%) | -$2.80M(+3.7%) |
| Mar 1996 | - | -$200.00K(-84.6%) | -$2.70M(-145.8%) |
| Dec 1995 | $5.90M(-49.1%) | -$1.30M(+18.2%) | $5.90M(-72.0%) |
| Sep 1995 | - | -$1.10M(+1000.0%) | $21.10M(-4.1%) |
| Jun 1995 | - | -$100.00K(-101.2%) | $22.00M(+5.3%) |
| Mar 1995 | - | $8.40M(-39.6%) | $20.90M(+80.2%) |
| Dec 1994 | $11.60M(-1.7%) | $13.90M(-7050.0%) | $11.60M(+11.5%) |
| Sep 1994 | - | -$200.00K(-83.3%) | $10.40M(+1.0%) |
| Jun 1994 | - | -$1.20M(+33.3%) | $10.30M(-8.0%) |
| Mar 1994 | - | -$900.00K(-107.1%) | $11.20M(-5.1%) |
| Dec 1993 | $11.80M(-427.8%) | $12.70M(-4333.3%) | $11.80M(-1411.1%) |
| Sep 1993 | - | -$300.00K(0.0%) | -$900.00K(-10.0%) |
| Jun 1993 | - | -$300.00K(0.0%) | -$1.00M(0.0%) |
| Mar 1993 | - | -$300.00K(-25.0%) | -$1.00M(-16.7%) |
| Dec 1992 | -$3.60M(+414.3%) | - | - |
| Oct 1992 | - | -$400.00K(+33.3%) | -$1.20M(+33.3%) |
| Jul 1992 | - | -$300.00K(0.0%) | -$900.00K(+28.6%) |
| Apr 1992 | - | -$300.00K(+50.0%) | -$700.00K(+40.0%) |
| Apr 1992 | -$700.00K(+75.0%) | - | - |
| Jan 1992 | - | -$200.00K(+100.0%) | -$500.00K(0.0%) |
| Oct 1991 | - | -$100.00K(0.0%) | -$500.00K(+25.0%) |
| Jul 1991 | - | -$100.00K(0.0%) | -$400.00K(0.0%) |
| Apr 1991 | -$400.00K(-55.6%) | -$100.00K(-50.0%) | -$400.00K(+33.3%) |
| Jan 1991 | - | -$200.00K(<-9900.0%) | -$300.00K(+200.0%) |
| Oct 1990 | - | $0.00(-100.0%) | -$100.00K(0.0%) |
| Jul 1990 | - | -$100.00K | -$100.00K |
| Apr 1990 | -$900.00K | - | - |
FAQ
- What is Celldex Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Celldex Therapeutics?
- What is Celldex Therapeutics annual CFI year-on-year change?
- What is Celldex Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly CFI year-on-year change?
- What is Celldex Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Celldex Therapeutics?
- What is Celldex Therapeutics TTM CFI year-on-year change?
What is Celldex Therapeutics annual cash flow from investing activities?
The current annual CFI of CLDX is -$290.13M
What is the all time high annual CFI for Celldex Therapeutics?
Celldex Therapeutics all-time high annual cash flow from investing activities is $89.94M
What is Celldex Therapeutics annual CFI year-on-year change?
Over the past year, CLDX annual cash flow from investing activities has changed by -$184.35M (-174.27%)
What is Celldex Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CLDX is $42.95M
What is the all time high quarterly CFI for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly cash flow from investing activities is $52.57M
What is Celldex Therapeutics quarterly CFI year-on-year change?
Over the past year, CLDX quarterly cash flow from investing activities has changed by +$358.16M (+113.63%)
What is Celldex Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CLDX is $68.03M
What is the all time high TTM CFI for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM cash flow from investing activities is $132.13M
What is Celldex Therapeutics TTM CFI year-on-year change?
Over the past year, CLDX TTM cash flow from investing activities has changed by +$541.59M (+114.37%)